Rl. Jilka et al., OSTEOBLAST PROGRAMMED CELL-DEATH (APOPTOSIS) - MODULATION BY GROWTH-FACTORS AND CYTOKINES, Journal of bone and mineral research, 13(5), 1998, pp. 793-802
Once osteoblasts have completed their bone-forming function, they are
either entrapped in bone matrix and become osteocytes or remain on the
surface as lining cells. Nonetheless, 50-70% of the osteoblasts initi
ally present at the remodeling site cannot be accounted for after enum
eration of lining cells and osteocytes, We hypothesized that the missi
ng osteoblasts die by apoptosis and that growth factors and cytokines
produced in the bone microenvironment influence this process. We repor
t that murine osteoblastic MC3T3-E1 cells underwent apoptosis followin
g removal of serum, or addition of tumor necrosis factor (TNF), as ind
icated by terminal deoxynucleotidyl transferase-mediated dUTP-nick end
labeling and DNA fragmentation studies, Transforming growth factor-be
ta and interleukin-6 (IL-6)-type cytokines had antiapoptotic effects b
ecause they were able to counteract the effect of serum starvation or
TNF, In addition, anti-Pas antibody stimulated apoptosis of human oste
oblastic MG-63 cells and IL-6-type cytokines prevented these changes,
The induction of apoptosis in MG-63 cells was associated with an incre
ase in the ratio of the proapoptotic protein bar to the antiapoptotic
protein bcl-2, and oncostatin M prevented this change. Examination of
undecalcified sections of murine cancellous bone revealed the presence
of apoptotic cells, identified as osteoblasts by their proximity to o
steoid seams and their juxtaposition to cuboidal osteoblasts, Assuming
an osteoblast life span of 300 h and a prevalence of apoptosis of 0.6
%, we calculated that the fraction that undergo this process in vivo c
an indeed account for the missing osteoblasts, These findings establis
h that osteoblasts undergo apoptosis and strongly suggest that the pro
cess can be modulated by growth factors and cytokines produced in the
bone microenvironment.